About NovoArc
NovoArc is a company based in Vienna (Austria) founded in 2021.. NovoArc offers products and services including Tetraether Lipids, Tailored Lipids, and API-Specific Formulations. NovoArc operates in a competitive market with competitors including Vesigen Therapeutics, Amarna Therapeutics, ACM Biolabs, Cuorips and Clavis Pharma, among others.
- Headquarter Vienna, Austria
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Novoarc Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NovoArc
NovoArc offers a comprehensive portfolio of products and services, including Tetraether Lipids, Tailored Lipids, and API-Specific Formulations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Lipids that protect APIs from degradation and enhance efficacy
Services for creating specific lipids to support drug development
Solutions to improve drug substance stability and delivery
Funding Insights of NovoArc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NovoArc
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NovoArc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novoarc Comparisons
Competitors of NovoArc
NovoArc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vesigen Therapeutics, Amarna Therapeutics, ACM Biolabs, Cuorips and Clavis Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-viral delivery platform for intracellular therapeutics using ARMMs technology
|
|
| domain | founded_year | HQ Location |
Viral gene delivery vectors are developed for diverse diseases.
|
|
| domain | founded_year | HQ Location |
Artificial membrane platforms are utilized for vaccine and antibody production.
|
|
| domain | founded_year | HQ Location |
Developer of drug delivery platform for heart failure
|
|
| domain | founded_year | HQ Location |
Develops innovative small molecule therapeutics for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of drug delivery technology
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NovoArc
When was NovoArc founded?
NovoArc was founded in 2021.
Where is NovoArc located?
NovoArc is headquartered in Vienna, Austria.
What does NovoArc do?
Founded in 2021 and based in Vienna, Austria, operations are centered in the biotechnology sector. Oral delivery systems for pharmaceuticals and food supplements are created through archaeosome technology. Drugs are encapsulated in liposomes formed from stable lipids, which resist low pH, high temperatures, oxidation, and bile salts. Shelf life is extended, gastric protection is provided, and bioavailability is enhanced for various therapeutic applications.
Who are the top competitors of NovoArc?
NovoArc's top competitors include Vesigen Therapeutics, Amarna Therapeutics and ACM Biolabs.
What products or services does NovoArc offer?
NovoArc offers Tetraether Lipids, Tailored Lipids, and API-Specific Formulations.